Tricuspid Regurgitation Clinical Trials

Find Tricuspid Regurgitation Clinical Trials Near You

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• tricuspid regurgitation

• qualification for transcatheter tricuspid valve intervention

Locations
Other Locations
Poland
First Department of Cardiology, Medical University of Warsaw
RECRUITING
Warsaw
Contact Information
Primary
Adam Rdzanek, MD PhD
adam.rdzanek@wum.edu.pl
4822 599 19 51
Backup
Mariusz Tomaniak, MD PhD Assoc. Prof.
mariusz.tomaniak@wum.edu.pl
4822 599 19 51
Time Frame
Start Date: 2023-11-14
Estimated Completion Date: 2028-07-01
Participants
Target number of participants: 300
Treatments
Medical therapy
Cohort of patients disqualified from transcatheter procedures and receiving medical therapy only.
Transcatheter edge to edge repair of the tricuspid valve
Patients undergoing transcatheter tricuspid valve edge-to-edge repair
Related Therapeutic Areas
Sponsors
Collaborators: Jagiellonian University, Medical University of Gdansk, Medical University of Silesia, Poznan University of Medical Sciences, National Institute of Cardiology, Warsaw, Poland
Leads: Medical University of Warsaw

This content was sourced from clinicaltrials.gov